Qing Dong - San Diego CA, US Bheema R. Paraselli - San Diego CA, US Nicholas Scorah - San Diego CA, US Jeffrey A. Stafford - San Diego CA, US Michael B. Wallace - San Diego CA, US
Assignee:
Takeda Pharmaceutical Company Limited - Osaka
International Classification:
A61K 31/437 C07D 471/04
US Classification:
514292, 546 81
Abstract:
Compounds, pharmaceutical compositions, kits and methods are provided for use with kinases that comprise a compound selected from the group consisting of:.
Jason W. Brown - San Diego CA, US Qing Dong - San Diego CA, US Bheema R. Paraselli - San Diego CA, US Nicholas Scorah - San Diego CA, US Jeffrey A. Stafford - San Diego CA, US Michael B. Wallace - San Diego CA, US Hasanthi Wijesekera - Brookwater, AU
Assignee:
Takeda Pharmaceutical Company Limited - Osaka
International Classification:
C07D 471/00 C07D 209/88
US Classification:
546 86, 548444
Abstract:
Compounds are provided for use with kinases that comprise a compound selected from the group consisting of:.
Qing Dong - San Diego CA, US David J. Hosfield - Solana Beach CA, US Bheema R. Paraselli - San Diego CA, US Nicholas Scorah - San Diego CA, US Jeffrey A. Stafford - San Diego CA, US Michael B. Wallace - San Diego CA, US Zhiyuan Zhang - San Diego CA, US
Assignee:
Takeda Pharmaceutical Company Limited - Osaka
International Classification:
C07D 487/04 A61K 31/517 A61P 19/02
US Classification:
544281, 5142591
Abstract:
Compounds, pharmaceutical compositions and kits are provided for use with kinases that comprise a compound selected from the group consisting of:.
Qing Dong - San Diego CA, US Nicholas Scorah - San Diego CA, US Steven W Kaldor - Del Mar CA, US
Assignee:
Takeda Pharmaceutical Company Limited - Osaka
International Classification:
C07D 471/04 A61K 31/519 A61P 35/00
US Classification:
544279
Abstract:
Compounds of the following formula are provided for use with MEK (I): wherein the variables are as defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds; methods and intermediates useful for making the compounds; and methods of using said compounds.
Qing Dong - San Diego CA, US Bheema R. Paraselli - San Diego CA, US Nicholas Scorah - San Diego CA, US Michael B. Wallace - San Diego CA, US Jeffrey A. Stafford - San Diego CA, US
Assignee:
Takeda Pharmaceutical Company Limited - Osaka
International Classification:
C07D 471/04 A61K 31/437
US Classification:
546 86, 514292
Abstract:
Compounds, pharmaceutical compositions, kits and methods are provided for use with kinases that comprise a compound selected from the group consisting of:.
Qing Dong - San Diego CA, US David Hosfield - Solana Beach CA, US Bheema Paraselli - San Diego CA, US Nicholas Scorah - San Diego CA, US Jeffrey Stafford - San Diego CA, US Michael Wallace - San Diego CA, US Zhiyuan Zhang - San Diego CA, US
International Classification:
A61K 31/53 C07D 487/04
US Classification:
514243000, 544184000
Abstract:
Compounds, pharmaceutical compositions and kits are provided for use with kinases that comprise a compound selected from the group consisting of: wherein the variables are as defined herein.